Finding Solutions to the Latest Challenges in Rx Drug Pricing
Both federal and state law makers are engaging in greater scrutiny of prescription drug pricing and now is the time when industry professionals must stay up to date on the latest amendments to government payor programs as well as their impact on the private sector.
ACI’s Rx Drug Pricing Forum will provide you with the guidance you need to formulate solutions to conquer the latest challenges drug manufacturers are facing in the public payor arena.
Join Our mailing list now to
receive updates on the agenda and speakers list
HIGHLIGHTS FROM THE 2019 CONFERENCE
Thank You to our 2019 Co-Chairs!
Jonathan Connell
Senior Corporate Counsel
Bristol-Myers Squibb
Meenakshi Datta
Partner
Sidley Austin LLP
Industry Keynote Address: Industry Perspectives on the Public Payor Landscape
James Stansel
Executive Vice President and General Counsel
PhRMA
BIO’s Thoughts on the Policies of Public Payors
John A. Murphy
Deputy General Counsel
Biotechnology Innovation Organization (Washington, D.C.)
Enforcers Roundtable on Rx Drug Pricing
Viveca Parker
Assistant U.S. Attorney
The United States Attorney’s Office for the Eastern District of Pennsylvania
Steve Sharobem
Assistant U.S. Attorney
The United States Attorney’s Office for the District of Massachusetts
MORE SESSIONS FROM 2019:
- The latest amendments to Medicare parts B and D under the CMS Proposed Final Rule
- The future of the PHS’s 340B program in the aftermath of American Hospital Association v. Azar
- The perplexities of co-pay coupons, maximizers and accelerators
- The expansion of federal and state transparency measures in relation to pricing
- The role of online pharmacies in the drug pricing debate
- The impact of pharmaceutical industry verticalization on prescription drug pricing under the Medicare and Medicaid programs
Don’t miss this opportunity to benchmark your drug pricing strategies with top industry representatives. Register now and enjoy early bird savings!
WHAT PAST ATTENDEES SAY:
“Excellent and fully capable list of speakers” -VP US Commercial Legal, Lundbeck LLC
“All encompassing overview of government programs and current issues” -Director, Pricing and Contracts, Horizon Pharmaceuticals
WHO YOU WILL MEET:
- Corporate Counsel/General Counsel
- Vice Presidents, Officers, Directors and Managers for:
- — Pricing, Pricing Strategy, Pricing Analytics
- — Contracts and Reimbursement
- — Managed Care
- — Government Programs
- — Medicaid/Medicare Rebates
- — Finance/Accounting/Audit
- — Government Affairs
- — Marketing
- Compliance Officers
- Attorneys with practice areas in:
- — Pharmaceuticals
- — Healthcare
- — Food & Drug
- Corporate Counsel/General Counsel
- Vice Presidents, Officers, Directors and Managers for:
- — Contract Management
- — Network Pharmacy
- — Retail Pharmacy Operations
- — Government Programs
- — Pricing and Operations
- — Clinical Operations
- — Industry Relations/Government Affairs
- Financial Analysts
- Corporate Counsel/General Counsel
- Vice Presidents, Officers, Directors and Managers for:
- Pricing
- Business Development
- Corporate Counsel/General Counsel
- Vice Presidents, Officers, Directors and Managers for:
- — Pharmacy Networks
- — Pharmaceutical Contracting
- — Clinical
- — Pharmacy Services
ACI’s Global Series of Life Sciences conferences bring together key sector stakeholders from around the globe to explore the most important trends impacting the many industries including pharmaceutical, biotechnology, medical device/diagnostics, and FDA-regulated consumer products. Our events cover every facet of legal and business relevance as well as controversy. Learn More
